Clear Rock Advisors LLC Has $1.78 Million Position in Humana Inc. (NYSE:HUM)

Clear Rock Advisors LLC increased its holdings in Humana Inc. (NYSE:HUM) by 4.0% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,131 shares of the insurance provider’s stock after purchasing an additional 199 shares during the period. Clear Rock Advisors LLC’s holdings in Humana were worth $1,779,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. Cetera Advisors LLC raised its position in Humana by 472.1% in the first quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock worth $3,501,000 after purchasing an additional 8,333 shares in the last quarter. Cetera Investment Advisers grew its stake in Humana by 249.0% during the first quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock worth $7,262,000 after buying an additional 14,944 shares during the last quarter. Atria Investments Inc grew its stake in Humana by 14.5% during the first quarter. Atria Investments Inc now owns 5,329 shares of the insurance provider’s stock worth $1,848,000 after buying an additional 673 shares during the last quarter. Swedbank AB bought a new stake in Humana during the first quarter worth about $37,174,000. Finally, Adams Wealth Management grew its stake in Humana by 69.9% during the first quarter. Adams Wealth Management now owns 5,969 shares of the insurance provider’s stock worth $2,070,000 after buying an additional 2,455 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Up 1.3 %

NYSE HUM traded up $4.64 during trading hours on Friday, hitting $363.62. The company’s stock had a trading volume of 1,076,306 shares, compared to its average volume of 1,396,067. The stock has a fifty day moving average of $367.90 and a 200 day moving average of $347.51. The company has a quick ratio of 1.67, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $43.78 billion, a P/E ratio of 22.64, a PEG ratio of 2.09 and a beta of 0.51. Humana Inc. has a twelve month low of $298.61 and a twelve month high of $530.54.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the business posted $8.94 earnings per share. Equities research analysts forecast that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have weighed in on the stock. Bank of America upped their price objective on shares of Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a research note on Monday, May 20th. Baird R W raised shares of Humana to a “hold” rating in a research note on Thursday, May 30th. TD Cowen upped their price objective on shares of Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a research note on Wednesday, July 24th. Truist Financial increased their price target on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a research note on Monday, July 15th. Finally, Wells Fargo & Company decreased their price target on shares of Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Fourteen analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average price target of $403.55.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.